These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 15153577

  • 1. Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation.
    Scheiber-Mojdehkar B, Lutzky B, Schaufler R, Sturm B, Goldenberg H.
    J Am Soc Nephrol; 2004 Jun; 15(6):1648-55. PubMed ID: 15153577
    [Abstract] [Full Text] [Related]

  • 2. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration.
    Parkkinen J, von Bonsdorff L, Peltonen S, Grönhagen-Riska C, Rosenlöf K.
    Nephrol Dial Transplant; 2000 Nov; 15(11):1827-34. PubMed ID: 11071973
    [Abstract] [Full Text] [Related]

  • 3. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron.
    Prakash M, Upadhya S, Prabhu R.
    Clin Chim Acta; 2005 Oct; 360(1-2):194-8. PubMed ID: 15979061
    [Abstract] [Full Text] [Related]

  • 4. Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
    Kooistra MP, Kersting S, Gosriwatana I, Lu S, Nijhoff-Schutte J, Hider RC, Marx JJ.
    Eur J Clin Invest; 2002 Mar; 32 Suppl 1():36-41. PubMed ID: 11886430
    [Abstract] [Full Text] [Related]

  • 5. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
    Pai AB, Conner T, McQuade CR, Olp J, Hicks P.
    Biometals; 2011 Aug; 24(4):603-13. PubMed ID: 21229380
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravenous ferric saccharate as an iron supplement in dialysis patients.
    Silverberg DS, Blum M, Peer G, Kaplan E, Iaina A.
    Nephron; 1996 Aug; 72(3):413-7. PubMed ID: 8852489
    [Abstract] [Full Text] [Related]

  • 8. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
    Parkes JG, Randell EW, Olivieri NF, Templeton DM.
    Biochim Biophys Acta; 1995 Apr 13; 1243(3):373-80. PubMed ID: 7727512
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients.
    Driss F, Vrtovsnik F, Katsahian S, Michel C, Baron G, Kolta A, Sedrati N, Mentré F, Mignon F, Cabantchik I, Grandchamp B.
    Nephron Clin Pract; 2005 Apr 13; 99(3):c63-7. PubMed ID: 15640610
    [Abstract] [Full Text] [Related]

  • 11. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
    Silverberg DS, Iaina A, Peer G, Kaplan E, Levi BA, Frank N, Steinbruch S, Blum M.
    Am J Kidney Dis; 1996 Feb 13; 27(2):234-8. PubMed ID: 8659499
    [Abstract] [Full Text] [Related]

  • 12. Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose.
    Barton Pai A, Pai MP, Depczynski J, McQuade CR, Mercier RC.
    Am J Nephrol; 2006 Feb 13; 26(3):304-9. PubMed ID: 16809897
    [Abstract] [Full Text] [Related]

  • 13. New Options for Iron Supplementation in Maintenance Hemodialysis Patients.
    Vaziri ND, Kalantar-Zadeh K, Wish JB.
    Am J Kidney Dis; 2016 Mar 13; 67(3):367-75. PubMed ID: 26616335
    [Abstract] [Full Text] [Related]

  • 14. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo.
    Rooyakkers TM, Stroes ES, Kooistra MP, van Faassen EE, Hider RC, Rabelink TJ, Marx JJ.
    Eur J Clin Invest; 2002 Mar 13; 32 Suppl 1():9-16. PubMed ID: 11886426
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
    Nguyen TV.
    Am J Health Syst Pharm; 2009 Jun 15; 66(12):1101-4. PubMed ID: 19498125
    [Abstract] [Full Text] [Related]

  • 17. Citrate and albumin facilitate transferrin iron loading in the presence of phosphate.
    Matias C, Belnap DW, Smith MT, Stewart MG, Torres IF, Gross AJ, Watt RK.
    J Inorg Biochem; 2017 Mar 15; 168():107-113. PubMed ID: 28110161
    [Abstract] [Full Text] [Related]

  • 18. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C, Temiz A, Yeniçerioğlu Y, Calişkan S, Celik A, Sifil A, Onvural B, Camsari T.
    Scand J Urol Nephrol; 2003 Mar 15; 37(1):77-82. PubMed ID: 12745750
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
    Deng Y, Wu J, Jia Q.
    Med Sci Monit; 2017 Mar 12; 23():1254-1260. PubMed ID: 28285317
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.